Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Record Plug-and-play starting point CSV / CSA

Record: Residual Risk Acceptance

A plug-and-play residual risk acceptance record for a validation or release decision: the risk that remains after controls, why the control did not eliminate it, the compensating control relied on, the impact if it materializes, the acceptance level, and the named acceptor, with a filled specimen and the regulations it satisfies.

Document type: Record

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use residual risk acceptance record. It is the artifact that makes the intellectual core of a release decision inspectable: validation never drives risk to zero, so someone with the right authority has to accept what remains, by name, with reasons. Use one record per residual risk that is not fully closed, or a single record with one row per risk where your quality system allows it. Replace every <<FILL: ...>> placeholder with your own specifics. A worked filled specimen follows the template. Verify each cited regulation against the current source before you rely on it.

Document control header

FieldEntry
Record titleResidual Risk Acceptance
Record number<<FILL: RRA-ID, e.g. RRA-2026-011>>
Associated system / process<<FILL: SYSTEM or PROCESS NAME>>
Associated VSR / release record<<FILL: VSR and release authorization numbers>>
Source risk assessment<<FILL: risk assessment doc number>>
Prepared by<<FILL: role, e.g. Validation lead>>
Date<<FILL: date>>

1. The residual risk

State the risk in one clear sentence. Do not describe it as “low and acceptable” until the analysis below justifies it.

FieldEntry
Risk description<<FILL: what could go wrong and to what: product quality, patient safety, data integrity>>
Source (deviation, gap, or design limit)<<FILL: reference, e.g. DEV-06>>
Original risk rating (pre-control)<<FILL: e.g. High, from the risk assessment>>

2. Why the control did not fully eliminate it

FieldEntry
Planned control<<FILL: the control that was supposed to remove the risk>>
Why it does not fully eliminate the risk<<FILL: technical or process reason; e.g. legacy source never captured the attribute>>

3. Compensating control now relied on

FieldEntry
Compensating or procedural control<<FILL: what now contains the risk, e.g. records read-only, flagged, excluded from decisions>>
How it is verified and maintained<<FILL: how you know the control is working and stays in place>>
Reference / SOP<<FILL>>

4. Impact if it materializes

FieldEntry
Consequence if the risk occurs despite the control<<FILL: honest statement of impact and its bounds>>
Detectability<<FILL: how a materialized risk would be detected>>
Residual risk rating (post-control)<<FILL: Low / Medium / High with basis>>

5. Acceptance

The acceptance level must match the residual rating: higher residual risk is accepted at a higher level (typically senior QA or a designated risk owner for high residual risk, not the validation engineer).

FieldEntry
Residual risk rating<<FILL: Low / Medium / High>>
Required acceptance level per procedure<<FILL: role authorized to accept this level>>
Re-evaluation trigger / review date<<FILL: event or date that reopens this acceptance>>
Tracking reference (if a condition of release)<<FILL: CAPA / action number, or N/A>>

6. Acceptance signatures

RoleNameSignatureDate
Prepared by (validation lead)<<FILL>>
Risk owner / SME<<FILL>>
Acceptor (authority matched to residual rating)<<FILL>>

7. References

ICH Q9(R1), Quality Risk Management (risk evaluation, risk acceptance, and residual risk). EU GMP Annex 11 and Annex 15 (qualification and validation; documented risk-based decisions). 21 CFR 211.22 (quality unit approval of matters affecting product quality). GAMP 5 (Second Edition, ISPE 2022) for risk-based validation and residual-risk treatment.

Confirm the current version and clause numbers before issue.


Filled specimen

The following shows the record completed for the archived-records attribution gap carried from an example LIMS validation.

FieldEntry
Record numberRRA-2026-011
Associated systemQC LIMS v7.2
SourceDEV-06 (VSR-LIMS-2026-004)

The residual risk. Three archived analytical results permanently lack the original analyst identity, an ALCOA+ attributable gap inherited from the legacy source system. Original rating: High (attribution is a data-integrity attribute).

Why the control did not eliminate it. Planned control was to migrate full metadata including analyst ID. The source system never stored analyst ID for these three records, so no migration step can recover it.

Compensating control. The three records are set read-only, flagged in the system, and excluded from use in any current release or disposition decision; a documented data-limitation note travels with each record. Verified during migration QC and confirmed at each periodic review.

Impact if it materializes. Limited: the records are historical and not used for current decisions, so a downstream reliance would be blocked by the flag. Detectability: high (records are flagged). Residual rating: Low.

Acceptance. Residual Low, but because the underlying attribute is data integrity, acceptance was escalated to Head of QA per procedure. Re-evaluation at the next periodic review. Accepted by Head of QA, 19 June 2026.

Notice what makes this defensible: the risk is named, the reason the control failed is technical and honest, the compensating control is real and verifiable, the impact is bounded, and the acceptance sits at the right level, not with the engineer who found it.

Common inspection findings this record prevents

  • “Residual risk is low and acceptable” asserted with no statement of the risk, the failed control, or the acceptor.
  • A high residual risk accepted by the validation engineer rather than an appropriate authority.
  • A compensating control named on paper but never verified or maintained.
  • A residual risk accepted once and never re-evaluated, so a temporary acceptance became a permanent gap.

How to adapt this record

  1. Open one record per residual risk that is not fully closed at release, and reference it from the release authorization.
  2. Force the analysis in sections 2 to 4 before you write a rating; the rating is a conclusion, not an opener.
  3. Match the acceptance level in section 5 to your procedure’s escalation thresholds for the residual rating.
  4. Set a real re-evaluation trigger or review date so the acceptance is revisited, and feed any action into tracking.
  5. Keep the wording specific: an inspector reads the reasoning, not just the rating.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.